Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Caldesmon inhibits actomyosin ATPase across smooth muscle types; leaves open its physiological role in Ca2+ regulation.
Thin-filament preparations from four smooth muscle types (gizzard, stomach, trachea, aorta) all activate myosin MgATPase activity, are regulated by Ca2+, and contain actin, tropomyosin and a 120000-140000-Mr protein in the molar proportions 1:1/7:1/26. The 120000-140000-Mr protein from all sources is a potent inhibitor of actomyosin ATPase activity. Peptide-mapping and immunological evidence is presented showing that it is identical with caldesmon. Quantitative immunological data suggest that caldesmon is a component of all the thin filaments and that the thin-filament-bound caldesmon accounts for all the caldesmon in intact tissue. The myosin light-chain kinase content of thin-filament preparations was found to be negligible. We propose that caldesmon-based thin-filament Ca2+ regulation is a physiological mechanism in all smooth muscles.
No takes yet. Share an insight, caveat, or question.
Marston et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: